Intellipharmaceutics International Inc. (IPCI)

[fred198484]

You may be right about that but the buyers of that offering would waive that condition if the company made a good case to do so. And running out of cash is a very good reason!

On China, the key is once again cash. Does any deal that gets done involve an upfront cash payment to IPCI? Drug prices in China are quite low, thus none of the major companies spend a lot of effort there. There may be some small business benefit coming from China if they are able to conclude a deal that brings IPCI upfront cash. In fact, getting cash in this manner is probably the best option as share issuance dilute our interest as do partnerships on our US-targeted products. But it is hard for me to see how China might be a game changer for IPCI.